{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:06:16Z","timestamp":1772118376643,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.drugalcdep.2015.11.014","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T06:27:12Z","timestamp":1448173632000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["\u201cTAARgeting Addiction\u201d\u2014The Alamo Bears Witness to Another Revolution"],"prefix":"10.1016","volume":"159","author":[{"given":"David K.","family":"Grandy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pbb.2011.10.025","article-title":"Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1","volume":"101","author":"Achat-Mendes","year":"2012","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157488707779318107","article-title":"The potential of trace amines and their receptors for treating neurological and psychiatric diseases","volume":"2","author":"Berry","year":"2007","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0015","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0020","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1139\/o72-164","article-title":"Binding of some primary aromatic amines to certain rat brain particulate fractions","volume":"50","author":"Boulton","year":"1972","journal-title":"Can. J. Biochem."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0025","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","article-title":"The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system","volume":"106","author":"Bradaia","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0030","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1017\/S0007114508123431","article-title":"Effects of dietary amines on the gut and its vasculature","volume":"101","author":"Broadley","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0035","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1073\/pnas.0401418101","article-title":"Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine","volume":"101","author":"Budygin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0040","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.21-09-j0001.2001","article-title":"Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene","volume":"21","author":"Carboni","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.neuropharm.2014.06.011","article-title":"Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes","volume":"85","author":"Cisneros","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnins.2015.00039","article-title":"The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects","volume":"9","author":"Cotter","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(03)00573-1","article-title":"HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes","volume":"346","author":"D\u2019Andrea","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0065","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0070","doi-asserted-by":"crossref","first-page":"16928","DOI":"10.1523\/JNEUROSCI.2502-11.2011","article-title":"Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA)","volume":"31","author":"Di Cara","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0071","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(98)00414-2","article-title":"Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior","volume":"353","author":"El-Ghundi","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0075","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1523\/JNEUROSCI.4177-08.2009","article-title":"Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs","volume":"29","author":"Eriksen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/mol.111.073304","article-title":"Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor","volume":"80","author":"Espinoza","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2015.02.010","article-title":"Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1","volume":"93","author":"Espinoza","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2008.03.055","article-title":"Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors","volume":"587","author":"Frascarelli","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0100","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0105","series-title":"Abstract #175.03\/OO6","article-title":"A G protein-coupled receptor mechanism of action distinguishes methamphetamine from cocaine","author":"Grandy","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pharmthera.2007.06.007","article-title":"Trace amine-associated receptor 1\u2014family archetype or iconoclast?","volume":"116","author":"Grandy","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"Aug","key":"10.1016\/j.drugalcdep.2015.11.014_bib0115","article-title":"Trace amine-associated receptor 1 activation silences GSK3(signaling of TAAR1 and D2R heteromers","author":"Harmeier","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0120","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/jm0505718","article-title":"Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues","volume":"49","author":"Hart","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1369-1600.2007.00051.x","article-title":"Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice","volume":"12","author":"Heidbreder","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(91)90672-I","article-title":"The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas","volume":"552","author":"Hiroi","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mi.5.1.6","article-title":"The economics of drug abuse: a quantitative assessment of drug demand","volume":"5","author":"Hursh","year":"2005","journal-title":"Mol. Interv."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0135","first-page":"18","article-title":"Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in rats","author":"Jing","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejphar.2015.06.019","article-title":"Trace amine-associated receptor 1: a promising target for the treatment of psychostimulant addiction","volume":"761","author":"Jing","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0145","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1124\/mol.60.6.1165","article-title":"Old drugs learn new tricks: insights from mammalian trace amine receptors","volume":"60","author":"Kim","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0150","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1476-5381.2010.00792.x","article-title":"Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells","volume":"160","author":"Ledonne","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2014.02.007","article-title":"Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors","volume":"81","author":"Leo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0160","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/jpet.107.132647","article-title":"Trace amine-associated receptor 1 modulates dopaminergic activity","volume":"324","author":"Lindemann","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.114.213116","article-title":"Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1","volume":"350","author":"Liu","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0170","first-page":"117","article-title":"Trace amine associated receptor 1 modulates behavioral effects of ethanol","volume":"7","author":"Lynch","year":"2013","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-4159.2010.07109.x","article-title":"The emerging role of trace amine associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity","volume":"116","author":"Miller","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0180","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1021\/jm201437t","article-title":"Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1)","volume":"55","author":"Miller","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0185","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/jpet.105.084459","article-title":"Primate trace amine receptor 1 modulation by the dopamine transporter","volume":"313","author":"Miller","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2007.08.006","article-title":"Expression of neuronal trace amine-associated receptor (TAAR) mRNAs in leukocytes","volume":"192","author":"Nelson","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0195","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s11481-011-9321-4","article-title":"Trace amine associated receptor 1 signaling in activated lymphocytes","volume":"7","author":"Panas","year":"2012","journal-title":"J. Neuroimmune. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0200","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/npp.2014.88","article-title":"Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking","volume":"39","author":"Pei","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2015.05.014","article-title":"Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds","volume":"63","author":"Pei","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0210","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1073\/pnas.181356198","article-title":"Following the trace of elusive amines","volume":"98","author":"Premont","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.0.CO;2-K","article-title":"Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter","volume":"30","author":"Pristupa","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/jpet.106.115402","article-title":"Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine","volume":"321","author":"Reese","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0225","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.1103029108","article-title":"TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity","volume":"108","author":"Revel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0230","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","article-title":"Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics","volume":"72","author":"Revel","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0235","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1038\/npp.2012.109","article-title":"Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine","volume":"37","author":"Revel","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0240","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/mp.2012.57","article-title":"A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight","volume":"18","author":"Revel","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0245","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/1152","article-title":"Cocaine self-administration in dopamine-transporter knockout mice","volume":"1","author":"Rocha","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00429541","article-title":"Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine","volume":"42","author":"Sabelli","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2012.00105","article-title":"BRET biosensors to study GPCR biology, pharmacology, and signal transduction","volume":"3","author":"Salahpour","year":"2012","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0260","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm1051","article-title":"3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone","volume":"10","author":"Scanlan","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2high dopamine receptors","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0275","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1021\/cb700057b","article-title":"Thyronamines inhibit plasma membrane and vesicular monoamine transport","volume":"2","author":"Snead","year":"2007","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0280","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1073\/pnas.95.13.7699","article-title":"Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice","volume":"95","author":"Sora","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0285","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1471-4159.2004.02721.x","article-title":"Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine","volume":"91","author":"Sotnikova","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0290","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002130100901","article-title":"Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter","volume":"159","author":"Spielewoy","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0295","article-title":"Methamphetamine induces trace amine-associated receptor 1 (TAAR1) expression in human T lymphocytes: role in immunomodulation","author":"Sriram","year":"2015","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0300","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bmcl.2010.12.075","article-title":"Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773)","volume":"21","author":"Stalder","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0305","doi-asserted-by":"crossref","DOI":"10.1159\/000434717","article-title":"Trace amine-associated receptor 1 localization at the apical plasma membrane domain of Fisher rat thyroid epithelial cells is confined to cilia","author":"Szumska","year":"2015","journal-title":"Eur. Thyroid. J."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0310","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/npp.2014.91","article-title":"Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats","volume":"39","author":"Thorn","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2014.02.024","article-title":"The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats","volume":"566","author":"Thorn","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0320","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/npp.2010.186","article-title":"A dopamine D1 receptor-dependent beta-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice","volume":"36","author":"Urs","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0325","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.pnpbp.2007.08.030","article-title":"Sensitization, drug addiction and psychopathology in animals and humans","volume":"31","author":"Vezina","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0330","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.106.112532","article-title":"Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1","volume":"320","author":"Wainscott","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0335","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.leukres.2011.10.002","article-title":"Evidence for functional trace amine associated receptor-1 in normal and malignant B cells","volume":"36","author":"Wasik","year":"2012","journal-title":"Leuk. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2015.11.014_bib0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0091-3057(80)80033-5","article-title":"Action of drugs of abuse on brain reward systems","volume":"13","author":"Wise","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-3623(83)90020-4","article-title":"Phenylethylamine in neuropsychiatric disorders","volume":"14","author":"Wolf","year":"1983","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0350","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","article-title":"The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia","volume":"6","author":"Wolinsky","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0355","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.106.117382","article-title":"Trace amine-associated receptor 1 is a modulator of the dopamine transporter","volume":"321","author":"Xie","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0360","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/jpet.107.134247","article-title":"Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain","volume":"325","author":"Xie","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0365","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.109.153775","article-title":"A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain","volume":"330","author":"Xie","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0370","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/jnr.21783","article-title":"Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association","volume":"86","author":"Xie","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0375","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.106.116863","article-title":"Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro","volume":"321","author":"Xie","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.11.014_bib0380","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/jpet.107.135079","article-title":"Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes","volume":"325","author":"Xie","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615017585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615017585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T19:53:30Z","timestamp":1567367610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615017585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":78,"alternative-id":["S0376871615017585"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.11.014","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTAARgeting Addiction\u201d\u2014The Alamo Bears Witness to Another Revolution","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}